Dosimetry of Auger-Electron-Emitting Radionuclides

[1]  S. Goddu,et al.  Radioprotection against biological effects of internal radionuclides in vivo by S-(2-aminoethyl)isothiouronium bromide hydrobromide (AET). , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  S. Goddu,et al.  Vitamins as radioprotectors in vivo. II. Protection by vitamin A and soybean oil against radiation damage caused by internal radionuclides. , 1994, Radiation research.

[3]  R. Howell,et al.  Auger Electron Emitters as Tools for Elucidating the Location of Primary Radiosensitive Targets , 1994 .

[4]  R. Howell,et al.  Relative biological effectiveness of alpha-particle emitters in vivo at low doses. , 1994, Radiation research.

[5]  S. Goddu,et al.  Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  R. Howell,et al.  Vitamins as radioprotectors in vivo. I. Protection by vitamin C against internal radionuclides in mouse testes: implications to the mechanism of damage caused by the Auger effect. , 1994, Radiation Research.

[7]  S. Goddu,et al.  Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  I. Gardin,et al.  The influence of tracer localization on the electron dose rate delivered to the cell nucleus. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  L. M. Cobb,et al.  Internal dosimetry using data derived from autoradiographs. , 1993, Journal of Nuclear Medicine.

[10]  A. D. Van den Abbeele,et al.  Tumor targeting in vivo and metabolic fate of 5-[iodine-125]iodo-2'-deoxyuridine following intratumoral injection in patients with colorectal cancer. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  R. Howell,et al.  On the equivalent dose for Auger electron emitters. , 1993, Radiation research.

[12]  R. Howell,et al.  Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  S. Strand,et al.  A quantitative autoradiographic study of the heterogeneous activity distribution of different indium-111-labeled radiopharmaceuticals in rat tissues. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  S. Strand,et al.  Radiation dosimetry for indium-111-labeled anti-CEA-F(ab')2 fragments evaluated from tissue distribution in rats. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  K. Hofer,et al.  The paradoxical nature of DNA damage and cell death induced by 125I decay. , 1992, Radiation research.

[16]  S. Adelstein,et al.  DNA damage produced in V79 cells by DNA-incorporated iodine-123: a comparison with iodine-125. , 1992, Radiation research.

[17]  K. Hofer.  Symposium report. Biophysical aspects of Auger processes. , 1992, International journal of radiation biology.

[18]  R K Ten Haken,et al.  Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography. , 1992, International journal of radiation oncology, biology, physics.

[19]  I. Morris,et al.  Metal radionuclides and the testis. , 1991, International journal of radiation biology.

[20]  R. Howell,et al.  The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells. , 1991, Radiation research.

[21]  E Pomplun,et al.  A new DNA target model for track structure calculations and its first application to I-125 Auger electrons. , 1991, International journal of radiation biology.

[22]  S. Sharma,et al.  Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours. , 1991, The British journal of radiology.

[23]  K. Bagshawe,et al.  Selective uptake of toxic nucleoside (125IUdR) by resistant cancer. , 1991, The British journal of radiology.

[24]  R. Howell,et al.  Biological consequence of nuclear versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger cascades in vivo. , 1990, Radiation research.

[25]  D. W. Vinter,et al.  Inhomogeneous deposition of radiopharmaceuticals at the cellular level: experimental evidence and dosimetric implications. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  S. Adelstein,et al.  Cellular radiation dosimetry and its implications for estimation of radiation risks. Illustrative results with technetium 99m-labeled microspheres and macroaggregates. , 1990, JAMA.

[27]  S. Adelstein,et al.  Implications of Radiobiological and Dosimetric Studies of DNA-Incorporated 123I: The Use of the Auger Effect as a Biological Probe at the Nanometre Level , 1990 .

[28]  J. Turner,et al.  Calculations of Physical and Chemical Reactions with DNA in Aqueous Solution from Auger Cascades , 1990 .

[29]  S. Adelstein,et al.  Limitations of conventional internal dosimetry at the cellular level. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  R. Howell,et al.  IN-VIVO RADIOTOXICITY OF DNA-INCORPORATED 125I COMPARED WITH THAT OF DENSELY IONISING ALPHA-PARTICLES , 1989, The Lancet.

[31]  J. Mclean,et al.  The Auger electron dosimetry of indium-111 in mammalian cells in vitro. , 1989, Radiation research.

[32]  M. Welch,et al.  Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine. , 1989, Radiation research.

[33]  S. Adelstein,et al.  Radiotoxicity of an 125I-labeled DNA intercalator in mammalian cells. , 1989, Radiation research.

[34]  D. Charlton,et al.  A method of calculating initial DNA strand breakage following the decay of incorporated 125I. , 1988, International journal of radiation biology and related studies in physics, chemistry, and medicine.

[35]  A. Wambersie,et al.  Which RBE for iodine 125 in clinical applications? , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  G. Makrigiorgos.  Calculation of the restricted dose mean LET of Auger electron emitters , 1987 .

[37]  S. Adelstein,et al.  Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. , 1987, Radiation research.

[38]  L. Feinendegen,et al.  A microdosimetric interpretation of the radiobiological effectiveness of125I and the problem of quality factor , 1987, Radiation and environmental biophysics.

[39]  D. Rao,et al.  Electron Dosimetry for Radioimmunotherapy: Optimal Electron Energy , 1985 .

[40]  D. Rao,et al.  Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[41]  M. Gaulden.  "Biological dosimetry" of radionuclides and radiation hazards. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  M. Welch,et al.  Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. , 1982, Radiation research.

[43]  G. Stöcklin,et al.  Chemical effects of iodine-125 decay in aqueous solution of 5-iodouracil. Ring fragmentation as a consequence of the Auger effect. , 1981, Radiation research.

[44]  S. Adelstein,et al.  Therapeutic application of iodine-125 labeled iododeoxyuridine in an early ascites tumour model. , 1978, Current topics in radiation research quarterly.

[45]  S. Adelstein,et al.  The radiotoxicity of iodine-125 in mammalian cells II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131TUdR, and 3HTdR. , 1976, Radiation research.

[46]  E. W. Bradley,et al.  The radiotoxicity of iodine-125 in mammalian cells. I. Effects on the survival curve of radioiodine incorporated into DNA. , 1975, Radiation research.

[47]  L. Feinendegen.  Biological damage from the Auger effect, possible benefits , 1975, Radiation and environmental biophysics.

[48]  L. Feinendegen,et al.  Inactivation of Mammalian Cells after Disintegrations of 3H or 125I in Cell DNA at −196°C , 1973 .

[49]  A. Cole.  Absorption of 20-eV to 50,000-eV electron beams in air and plastic. , 1969, Radiation research.